Literature DB >> 10681642

Mechanisms causing muscle proteolysis in uremia: the influence of insulin and cytokines.

W E Mitch1, J Du, J L Bailey, S R Price.   

Abstract

Decreased muscle mass in patients with chronic renal failure (CRF) can be caused by mechanisms that activate the ubiquitin-proteasome proteolytic system. This system accelerates the degradation of muscle protein. Concurrent with muscle protein breakdown, there is an increase in transcription of genes encoding components of this pathway, including ubiquitin and subunits of the proteasome. Potential activating signals include metabolic acidosis which stimulates proteolysis in CRF patients and in muscle of rats with CRF by a mechanism involving glucocorticoids. In CRF patients, there is insulin resistance and high circulating levels of tumor necrosis factor and other cytokines. As the ubiquitin-proteasome proteolytic system is activated in acute diabetes and in catabolic conditions associated with high levels of circulating cytokines, these factors could also activate this pathway. Consequently, we examined whether the transcription factor activated by certain cytokines, NF-kappaB, is involved in the transcriptional regulation of subunits of the 26S proteasome complex. The results suggest that cytokines may be involved in the regulation of muscle protein degradation in uremia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10681642     DOI: 10.1159/000057450

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  9 in total

Review 1.  Nutrition in patients on peritoneal dialysis.

Authors:  Seung-Hyeok Han; Dae-Suk Han
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

Review 2.  The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy.

Authors:  Victoria C Foletta; Lloyd J White; Amy E Larsen; Bertrand Léger; Aaron P Russell
Journal:  Pflugers Arch       Date:  2011-01-11       Impact factor: 3.657

3.  Bicarbonate supplementation slows progression of CKD and improves nutritional status.

Authors:  Ione de Brito-Ashurst; Mira Varagunam; Martin J Raftery; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

Review 4.  Acidosis: progression of chronic kidney disease and quality of life.

Authors:  Ione de-Brito Ashurst; Emma O'Lone; Tarun Kaushik; Kieran McCafferty; Muhammad M Yaqoob
Journal:  Pediatr Nephrol       Date:  2014-08-02       Impact factor: 3.714

5.  Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile.

Authors:  Mark D Deboer; Xinxia Zhu; Peter R Levasseur; Akio Inui; Zhaoyong Hu; Guofeng Han; William E Mitch; John E Taylor; Heather A Halem; Jesse Z Dong; Rakesh Datta; Michael D Culler; Daniel L Marks
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

6.  Role of leptin and melanocortin signaling in uremia-associated cachexia.

Authors:  Wai Cheung; Pin X Yu; Brian M Little; Roger D Cone; Daniel L Marks; Robert H Mak
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

7.  Long-term retrospective observation study to evaluate effects of adiponectin on skeletal muscle in renal transplant recipients.

Authors:  Hiroki Adachi; Keiji Fujimoto; Ai Fujii; Keita Yamasaki; Keiichiro Okada; Toshikazu Matsuura; Kazuaki Okino; Kengo Furuichi; Hitoshi Yokoyama
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

8.  Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.

Authors:  Biagio R Di Iorio; Antonio Bellasi; Kalani L Raphael; Domenico Santoro; Filippo Aucella; Luciano Garofano; Michele Ceccarelli; Luca Di Lullo; Giovanna Capolongo; Mattia Di Iorio; Pasquale Guastaferro; Giovambattista Capasso
Journal:  J Nephrol       Date:  2019-10-09       Impact factor: 3.902

Review 9.  Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.

Authors:  Pablo Molina; Juan J Carrero; Jordi Bover; Philippe Chauveau; Sandro Mazzaferro; Pablo Ureña Torres
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-07-03       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.